HOME >> BIOLOGY >> NEWS
Study suggests cell-cycle triggers might be cancer drug targets

BOSTON--In an experiment that appears to refute current theory, Dana-Farber Cancer Institute scientists have found that removing three key proteins believed essential to cell division and growth had little impact on normal tissue development of a mouse embryo. These same proteins, when overly active, have been linked to cancer cell proliferation.

With one significant exception, the absence of proteins called cyclin D1, D2, and D3 seemed to have no deleterious effect on development of the tissues and organs of laboratory mouse embryos. "D-type cyclins" are molecules that sense growth signals from the cell's environment and, when appropriate, switch on cell division and growth. But when the system is faulty, the cyclins over-respond to the growth signals and can cause cancerous growth. The discovery that these proteins aren't indispensable lends encouragement to an idea that blocking overactive cyclins could halt the growth of cancer.

In the Aug. 20 issue of Cell, lead author Katarzyna Kozar, MD, and senior author Peter Sicinski, MD, PhD, report on developing the first mouse embryos to date in which all three D-type cyclins were absent or "knocked out." It had been thought that at least one cyclin was required for an embryo to be viable and its tissues to form normally. Yet the "triple-knockout" mouse embryos followed a normal course of cell division and proliferation until as late as 13.5 days, when most tissues and organs are already formed. A typical mouse pregnancy last 18 days.

(In a companion paper in Cell, researchers from Spain report similar findings involving protein kinases called CDK4 and CDK6, which are molecular partners of the D-cyclins. Embryonic mice with both CDK molecules knocked out had normal tissue development as well.)

The unexpectedly viable embryos contradict theory and previous laboratory experiments. The only abnormality in the triple knockout mice was a deficiency of blood-forming cells, causing them to be pa
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
19-Aug-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... PLEASANTON, Calif. (PRWEB) , ... November 19, 2018 ... ... of Emsculpt in the Bay Area -- the first and only non-invasive ... muscle contractions, Emsculpt is FDA cleared to strengthen, tone and firm the buttocks ...
(Date:11/16/2018)... , ... November 16, 2018 , ... ... is called All Things Chemical™ and it will engage listeners in intelligent, insightful ... and business issues surrounding chemicals. B&C’s talented team of lawyers, scientists, and consultants ...
(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research on merger and ... investment bankers and M&A advisors worldwide to compile the third annual M&A Fee ... findings in the report. , Highlights in the 2018-19 Report:, ...
Breaking Biology News(10 mins):
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of nominations for ... outstanding performance by individuals under 30 years of age. The Forbes 30 Under 30 ... and Entertainment to Venture Capital and Science. , In 2017, Visikol CEO Dr. ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... practices in Alpharetta and Sandy Springs, now welcomes new patients for MTM® Clear ... and comfortable alternative to traditional braces in the Sandy Springs and Alpharetta areas. ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... PhD, co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its Scientific ... world, Dr. Valenzuela brings to uBiome expertise on the genetic studies of hepatitis ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial Data ... data collection and management. TrialKit ™, an eClinical platform, has incorporated Apple’s ... quickly and easily sign in to the app via facial recognition or fingerprint ...
Breaking Biology Technology:
Cached News: